Category: Medmonitor

January 23, 2023
HIV Medications: New Approval and News of Discontinuations

Sunlenca approved for treatment-resistant populations, but a number of other drugs will cease production, some of which are included in PEP guidelines.

READ MORE
December 21, 2022
FDA Approves Drug That Can Delay Onset of Type 1 Diabetes

Tzield (teplizumab-mzwv) injections can delay onset by several months or years.

READ MORE
November 17, 2022
Wave of Generic Approvals That Impact Workers’ Comp

First-time generics are available for drugs that treat COPD, HIV, hypertension, and more.

READ MORE
October 18, 2022
FDA Advises Against NSAID Use in Pregnant Women at 20 Weeks and Later

The potential for low amniotic fluid can cause significant health issues.

READ MORE
September 28, 2022
Auvelity Approved for Major Depressive Disorder

This antidepressant can yield results as soon as one week, which could generate popularity.

READ MORE
August 25, 2022
FDA Authorizes New COVID-19 Vaccine

Novavax COVID-19 Vaccine, Adjuvanted will require two doses given three weeks apart.

READ MORE
July 20, 2022
FDA Recalls Morphine Sulfate ER Due to Potentially Deadly Label Mix-Up

A mix-up between 30 mg and 60 mg tablets could cause severe adverse events.

READ MORE
June 24, 2022
Walmart Recalls Supplement for Joint Pain Due to Hidden Drug Ingredients

Artri Ajo King contains undeclared diclofenac, creating safety concerns.

READ MORE
May 18, 2022
FDA Issues Warning for Consumer Products with Hidden Pain Medications

Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.

READ MORE
April 22, 2022
Phase 2 Trials for Non-Opioid Pain Medication Deliver Promising Results

VX-548 delivered significant improvements in pain with few adverse events.

READ MORE
1 2 3 6
lockenvelopephone-handsetmenucross-circle